NCT02998242View on ClinicalTrials.gov

Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 10, 2016

Primary Completion Date

January 5, 2017

Study Completion Date

December 10, 2017

Conditions

Quality of Life

Interventions

DRUG

Apatinib

RADIATION

SBRT to symptomatic bony metastatic bony site(s)

Sponsors

Collaborators (1)

Hainan Medical College

All Listed Sponsors

collaborator

Chang'An Hospital

OTHER

collaborator

Hainan Medical College

OTHER

lead

Sichuan Provincial People's Hospital

OTHER